Our study demonstrated that treatment of RT4 and T24 bladder cancer cells with sorafenib or CR-BAY 5:1 reduced Akt and Erk phosphorylation, which may be closely related to the decrease in proliferation and induction of apoptosis we observed. This evidence concerns the gene AKT1 and urinary bladder cancer.